Article Details
Retrieved on: 2022-07-29 10:26:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca saw first half revenues rise by 48 per cent to $22.2bn, ignoring the impact of exchange rates.
Article found on: www.cityam.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here